Synthesis and Anticancer Activities of New Benzothiadiazinyl Hydrazinecarboxamides and Anilino[1,2,4]triazolo[1,5-b][1,2,4]thiadiazine 5,5-diones
作者:Ahmed Kamal、Y. V.V. Srikanth、Md. Ashraf、M. Naseer A. Khan、Thokhir Basha Shaik、Shasi V. Kalivendi、Nitasha Suri、A. K. Saxena
DOI:10.2174/157340611795564259
日期:2011.5.1
Two series of compounds (5-14 and 15-23) based on the scaffolds of 2-(1,1-dioxido-4-phenyl-4Hbenzo [e][1,2,4]thiadiazin-3-yl)-N-(4-methoxyphenyl)hydrazinecarboxamide (5) and 2-((4-methoxyphenyl)amino)-10- phenyl-10H-benzo[e][1,2,4]triazolo[1,5-b][1,2,4]thiadiazine 5,5-dioxide (15) respectively, were designed and synthesized. These compounds were tested for anticancer activity against various cancer cell lines including lung, ovary, prostate, breast and colon cancers. They exhibited moderate to good inhibitory activity against the above cell lines and compound 9 was found to be the most active one from these two series. Further studies showed that cancer cell growth inhibition by compounds 22 and 23 could be in part due to the inhibition of tubulin polymerization, with the IC50 values of 4.70 and 5.25 μM, respectively.
分别基于2-(1,1-dioxido-4-phenyl-4Hbenzo [e][1,2,4]thiadiazin-3-yl)-N-(4-methoxyphenyl)hydrazinecarboxamide (5)和2-((4-methoxyphenyl)amino)-10- phenyl-10H-benzo[e][1,2,4]triazolo[1,5-b][1,2,4]thiadiazine 5,5-dioxide (15)骨架的两组化合物(5-14和15-23)被设计并合成。这些化合物被测试对包括肺癌、卵巢癌、前列腺癌、乳腺癌和结肠癌在内的各种癌细胞系的抗癌活性。它们对上述细胞系表现出中等至良好的抑制活性,并且化合物9被发现在这两个系列中是最活跃的。进一步的研究表明,化合物22和23对癌细胞生长的抑制可能部分是由于对微管蛋白聚合的抑制,IC50值分别为4.70和5.25μM。